Your browser doesn't support javascript.
One-year durability of anti-spike IgG to SARS-CoV-2: Preliminary data from the anticrown prospective observational study one year durability of COVID-19 anti-spike IgG.
Capetti, Amedeo F; Borgonovo, Fabio; Mileto, Davide; Gagliardi, Gloria; Mariani, Chiara; Lupo, Angelica; Dedivitiis, Gianfranco; Meraviglia, Paola; Pellicciotta, Martina; Armiento, Luciana; Cossu, Maria V; Rizzardini, Giuliano.
  • Capetti AF; Department of Infectious Diseases, Luigi Sacco University Hospital, ASST Fatebenefratelli-Sacco, Milan, Italy. Electronic address: amedeo.capetti@unimi.it.
  • Borgonovo F; Department of Infectious Diseases, Luigi Sacco University Hospital, ASST Fatebenefratelli-Sacco, Milan, Italy.
  • Mileto D; Clinical Microbiology Unit, Luigi Sacco University Hospital, ASST Fatebenefratelli-Sacco, Milan, Italy.
  • Gagliardi G; Clinical Microbiology Unit, Luigi Sacco University Hospital, ASST Fatebenefratelli-Sacco, Milan, Italy.
  • Mariani C; Università Statale of Milan, Milan, Italy.
  • Lupo A; Department of Infectious Diseases, Luigi Sacco University Hospital, ASST Fatebenefratelli-Sacco, Milan, Italy.
  • Dedivitiis G; Department of Infectious Diseases, Luigi Sacco University Hospital, ASST Fatebenefratelli-Sacco, Milan, Italy.
  • Meraviglia P; Department of Infectious Diseases, Luigi Sacco University Hospital, ASST Fatebenefratelli-Sacco, Milan, Italy.
  • Pellicciotta M; Department of Infectious Diseases, Luigi Sacco University Hospital, ASST Fatebenefratelli-Sacco, Milan, Italy.
  • Armiento L; Department of Infectious Diseases, Luigi Sacco University Hospital, ASST Fatebenefratelli-Sacco, Milan, Italy.
  • Cossu MV; Department of Infectious Diseases, Luigi Sacco University Hospital, ASST Fatebenefratelli-Sacco, Milan, Italy.
  • Rizzardini G; Department of Infectious Diseases, Luigi Sacco University Hospital, ASST Fatebenefratelli-Sacco, Milan, Italy.
J Infect ; 83(2): 237-279, 2021 08.
Article in English | MEDLINE | ID: covidwho-1244767
ABSTRACT
Data are presented of 368/503 post-COVID-19 outpatients followed within the AntiCROWN Cohort who have a one-year control and a baseline assessment of anti-S1/S2 antibodies, detected with the The LIAISON® SARS-CoV-2 S1/S2 IgG solution by DiaSorin. Loss of response occurred in 4 subjects having a baseline level below 50 AU/mL.
Subject(s)
Keywords
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: SARS-CoV-2 / COVID-19 Type of study: Cohort study / Observational study / Prognostic study Topics: Long Covid Limits: Humans Language: English Journal: J Infect Year: 2021 Document Type: Article

Similar

MEDLINE
LILACS
LIS
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: SARS-CoV-2 / COVID-19 Type of study: Cohort study / Observational study / Prognostic study Topics: Long Covid Limits: Humans Language: English Journal: J Infect Year: 2021 Document Type: Article